Asia-Pacific Newborn Screening Market - Industry Trends and Forecast to 2026

Asia-Pacific Newborn Screening Market - Industry Trends and Forecast to 2026

Short Description

By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics), Country (Japan, China, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific)
Market Definition:
Asia-Pacific market for newborn screening is considered to be one of the most expanding markets in the global healthcare industry. Newborn screening is the testing that diagnoses harmful and fatal disorders in newborns which can adversely affect their long term health. The newborn screening tests can detect around thirty metabolic and genetic diseases and some common are phenylketonuria (PKU), congenital hypothyroidism (CH), galactosemia (GAL), and sickle cell disease. Increased government initiatives to aware people regarding newborn screening are playing a vital role in expansion of newborn screening market. Newborn screening is a mandatory test in over 60 countries including U.S., Australia, and New Zealand. These countries have an Infant Mortality Rate of less than 10 per 1000 births. However, in India, only less than 1.0% of infants are screened and every year over 1.6 million babies are born with birth defects.
Market Segmentation:
Asia-Pacific newborn screening market is segmented into five notable segments which are test type, product type, technology, disease type and end user.
• On the basis of test type, the market is segmented into dried blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test.
• On the basis of product type, the market is segmented into instruments, reagents & assay kits.
• On the basis of technology, the market is segmented into tandem mass spectrometry, hearing screen technology, pulse oximetry screening technology, immunoassays and enzymatic assays, electrophoresis, DNA-based assays.
• On the basis of disease type, the market is segmented into phenylketonuria (PKU), cystic fibrosis (CF), sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease, others.
• On the basis of end user, the market is segmented into pediatric clinics, hospital, clinics.
Market Players
The key market players for Asia-Pacific newborn screening market are listed below:
• PerkinElmer Inc.
• Natus Medical Incorporated
• Trivitron Healthcare
• Baebies, Inc.
• Bio-Rad Laboratories, Inc.
• Danahar
• Hill-Rom Services Inc.
• Intelligent Hearing Systems
• Interacoustics A/S
• Masimo
• Medtronic
• Otodynamics Ltd
• Vivosonic Inc.
• ZenTech S.A.
• Others

The single user license is non-downloadable and non-printable. Global Site license allows these actions.

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia-pacific Newborn Screening Market
1.4 Limitations
1.5 Currency And Pricing
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Secondary Sources
2.7 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Rising Prevalence Of Newborn Screening
3.1.2 Growth In Neonatal Diseases
3.1.3 Increased Government Initiatives
3.1.4 Technological Advancements In Screening
3.2 Restraints
3.2.1 Stringent Regulatory Policies
3.2.2 High Cost Of Automated Devices
3.3 Opportunities
3.3.1 Next-generation Sequencing Technology For Newborn Screening
3.3.2 Emerging Market
3.4 Challenges
3.4.1 Socio Economic Barriers
3.4.2 Lack Of Skilled Professionals
4 Executive Summary
5 Premium Insights
6 Asia-pacific Newborn Screening Market, By Test Type
6.1 Overview
6.2 Dried Blood Spot Test
6.3 Hearing Screen Test
6.4 Critical Congenital Heart Diseases (Cchd) Test
7 Asia-pacific Newborn Screening Market, By Product Type
7.1 Overview
7.2 Instruments
7.2.1 Newborn Disorder Screening Instruments
7.2.2 Newborn Hearing Screening Instruments
7.2.3 Pulse Oximeter
7.3 Reagents And Assay Kits
8 Asia-pacific Newborn Screening Market, By Technology
8.1 Overview
8.2 Tandem Mass Spectrometry
8.3 Hearing Screen Technology
8.4 Pulse Oximetry Screening Technology
8.5 Immunoassays And Enzymatic Assays
8.6 Electrophoresis
8.7 Dna-based Assays
9 Asia-pacific Newborn Screening Market, By Disease Type
9.1 Overview
9.2 Critical Congenital Heart Diseases
9.3 Newborn Hearing Loss
9.4 Sickle Cell Disease
9.5 Phenylketonuria (Pku)
9.6 Cystic Fibrosis (Cf)
9.7 Maple Syrup Urine Disease
9.8 Others
10 Asia-pacific Newborn Screening Market, By End User
10.1 Overview
10.2 Hospital
10.3 Pediatric Clinics
10.4 Clinics
11 Asia-pacific Newborn Screening Market, By Geography
11.1 Asia-pacific
11.1.1 Japan
11.1.2 China
11.1.3 India
11.1.4 South Korea
11.1.5 Australia
11.1.6 Singapore
11.1.7 Thailand
11.1.8 Malaysia
11.1.9 Indonesia
11.1.10 Philippines
11.1.11 Vietnam
11.1.12 Rest Of Asia-pacific
12 Asia-pacific Newborn Screening Market, Company Landscape
12.1 Company Share Analysis: Asia Pacific
13 Company Profiles
13.1 Perkinelmer Inc.
13.1.1 Company Snapshot
13.1.2 Revenue Analysis
13.1.3 Product Portfolio
13.1.4 Recent Developments
13.2 Natus Medical Incorporated
13.2.1 Company Snapshot
13.2.2 Revenue Analysis
13.2.3 Product Portfolio
13.2.4 Recent Developments
13.3 Trivitron Healthcare
13.3.1 Company Snapshot
13.3.2 Product Portfolio
13.3.3 Recent Developments
13.4 Baebies, Inc.
13.4.1 Company Snapshot
13.4.2 Product Portfolio
13.4.3 Recent Developments
13.5 Bio-rad Laboratories, Inc.
13.5.1 Company Snapshot
13.5.2 Revenue Analysis
13.5.3 Product Portfolio
13.5.4 Recent Development
13.6 Danaher
13.6.1 Company Snapshot
13.6.2 Revenue Analysis
13.6.3 Product Portfolio
13.6.4 Recent Development
13.7 Hill-rom Services Inc.
13.7.1 Company Snapshot
13.7.2 Revenue Analysis
13.7.3 Product Portfolio
13.7.4 Recent Development
13.8 Intelligent Hearing Systems
13.8.1 Company Snapshot
13.8.2 Product Portfolio
13.8.3 Recent Development
13.9 Interacoustics A/S
13.9.1 Company Snapshot
13.9.2 Product Portfolio
13.9.3 Recent Developments
13.10 Masimo
13.10.1 Company Snapshot
13.10.2 Revenue Analysis
13.10.3 Product Portfolio
13.10.4 Recent Development
13.11 Medtronic
13.11.1 Company Snapshot
13.11.2 Revenue Analysis
13.11.3 Product Portfolio
13.11.4 Recent Development
13.12 Otodynamics Ltd
13.12.1 Company Snapshot
13.12.2 Product Portfolio
13.12.3 Recent Developments
13.13 Vivasonic Inc.
13.13.1 Company Snapshot
13.13.2 Product Portfolio
13.13.3 Recent Developments
13.14 Zentech S.A.
13.14.1 Company Snapshot
13.14.2 Product Portfolio
13.14.3 Recent Developments
14 Questionnaire
15 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook